本页面由Tiger Trade Technology Pte. Ltd.提供服务

ARS PHARMACEUTICALS INC

10.49
+0.67006.82%
盘后10.530.0400+0.38%19:56 EST
成交量:286.73万
成交额:3,018.91万
市值:10.37亿
市盈率:-12.86
高:10.99
开:9.84
低:9.80
收:9.82
52周最高:18.90
52周最低:6.66
股本:9,884.86万
流通股本:5,527.05万
量比:1.87
换手率:5.19%
股息:- -
股息率:- -
每股收益(TTM):-0.8154
每股收益(LYR):0.0825
净资产收益率:-45.92%
总资产收益率:-19.22%
市净率:7.02
市盈率(LYR):127.14

数据加载中...

2025/05/02

重要事件披露

Form 8-K - Current report
2025/04/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/20

重要事件披露

Form 8-K - Current report
2025/03/05

重要事件披露

Form 8-K - Current report
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities